Xr Securities LLC Editas Medicine, Inc. Call Options Transaction History

Xr Securities LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 29, 2021	SELL	$39.71 - $90.58 $337,535 - $769,930	-8,500 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$27.07 - $84.35 $230,095 - $716,975	8,500 New	8,500 $256,000
Q3 2020 Oct 28, 2020	SELL	$28.06 - $37.16 $283,406 - $375,315	-10,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.5 - $34.34 $186,850 - $346,834	10,100 New	10,100 $6,000
Q1 2020 Apr 09, 2020	SELL	$14.88 - $32.78 $312,480 - $688,380	-21,000 Closed	0 $0
Q4 2019 Jan 06, 2020	BUY	$19.49 - $32.63 $409,289 - $685,230	21,000 New	21,000 $8,000

225

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $132M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.